A total of 87 women were included in the study. Characteristics and
treatment of patients in group 1 (n = 52) and group 2 (n = 35) are
shown in Table 1. Blood loss before second-line therapy was initiated,
total blood loss, and the time between placental separation and application
of second-line therapy were significantly higher in group 2 than in
group 1 (P b 0.001) (Table 2). Fibrinogen levels in group 2 were significantly
lower than in group 1 (P b 0.001) (Table 2).